An exploratory, multicenter, randomized, open-label with blind evaluation, active-controlled study to evaluate the safety and efficacy of Keramod® (imiquimod 50 mg/g, Gel) compared with Aldara® (imiquimod 50 mg/g, Cream) for the treatment of actinic keratosis in adults.
RecruitingCTIS2024-515667-60-00
Laboratorios Ojer Pharma S.L.Actinic keratosis
Start: 2020-01-14Target: 68Updated: 2025-06-23